Back to Search
Start Over
930MO PD-L1 expression and outcomes of pembrolizumab and placebo in completely resected stage IB-IIIA NSCLC: Subgroup analysis of PEARLS/KEYNOTE-091
- Source :
- Annals of Oncology. 33:S971-S972
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Hematology
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........fa5b0f2ef31d8d2713880d36c32ef074
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.1056